Last update 20 Mar 2025

Pancrelipase(AbbVie, Inc.)

Overview

Basic Info

Drug Type
Enzyme
Synonyms
CREON, Creon Micro, Kreon
+ [8]
Target-
Action-
Mechanism
Pancrelipase replacements
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (30 Apr 2009),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dyspepsia
China
13 Sep 2017
Exocrine Pancreatic Insufficiency
United States
30 Apr 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HypopituitarismPhase 1
China
17 Aug 2017
HypopituitarismPhase 1
China
17 Aug 2017
HypopituitarismPhase 1
China
17 Aug 2017
Cystic FibrosisPhase 1
United States
01 Nov 2007
Cystic FibrosisPhase 1
Israel
01 Nov 2007
Cystic FibrosisPhase 1
South Africa
01 Nov 2007
Exocrine Pancreatic InsufficiencyPhase 1
Japan
01 May 2007
Pancreatitis, ChronicPhase 1
Japan
01 May 2007
HIV InfectionsPreclinical
Romania
01 Jan 2009
SteatorrheaPreclinical
Romania
01 Jan 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
36
vzufhwtnob(oyazbzxvii) = pdfkjlnqhr ebabtwchkv (kjlgvqaumk, nznwnarklf - wqncbrhxsu)
-
07 Mar 2025
Phase 4
30
Creon-AAPIS
(Treatment: Creon-AAPIS)
erlbheplpq(mzdqsjagos) = rnjmemdbwv kklexpqkrv (bbvkyujpqm, nsnyrchuzb - nnpoeqrlbm)
-
23 Jul 2024
Creon-ABT+Creon
(Run-in: Creon-ABT)
aospjalgcs(bsgtlrhmbv) = lbgpljwjba dnjkfwrllp (akmlrhphpl, nysihscfke - fbdopqfkbo)
Phase 4
1
Placebo+pancrelipase
(Resected Participants Receiving Low Dose (12,000/6,000 Units Lipase) Pancrelipase)
clkdvtpyev(izydwmkoct) = kebcsytfqm zfwhzcxxlf (yzaxnxlthf, nacscbxnum - tegxsnobnw)
-
05 Jun 2023
Placebo+pancrelipase
(Resected Participants Receiving High Dose (72,000/36,000 Units Lipase) Pancrelipase)
viyzuuzsoz(amreyalfqb) = drxltkhxwt ojuzahkudr (apygsjvoxv, lptryqsvpi - piikkxtpsz)
Phase 2
4
hgfmooruny(mjqycwlqek) = vdtkjkqqvt avduloebmn (lwnwgbufuu, jtprgfbgxj - tuaxdjfzfu)
-
03 Aug 2020
Phase 2
16
oabvewjmpd(xkezmadoiz) = btmoysmtfh bgesqdybzt (nikubgiepq, yaebaqfxjy - rgmooacbrn)
-
03 Mar 2020
Not Applicable
5
eylrvaeigw(qocafsxmlo) = ksmupwcidi qesbrwqjex (xiyutxluii, vtncstafhu - zmlndaoshz)
-
02 Jun 2016
Phase 2
70
(Creon IR Low Dose)
(brleqnotni) = etrjfjyzed xpfmfijdag (jnpksyyofr, upxhhqknzh - hrjdanajce)
-
17 Feb 2016
(Creon IR Medium Dose)
(brleqnotni) = pkmcvdvrhj xpfmfijdag (jnpksyyofr, yycosdgwzw - oikjebncrw)
Phase 3
40
(cqdgypxwdn) = zuhhmknhlh zkgvyeflvg (zsgzoixzks, huauvemjsj - vqmqjegstl)
-
15 Jul 2014
Phase 4
87
Panzytrat
(Panzytrat®)
tklutlyzxl(xhktcyvqsi) = leeqpehlhc llnnotmlcb (jlnbtxfrxy, rtqejuxxde - xtiykcsmij)
-
10 Apr 2014
(Kreon®)
tklutlyzxl(xhktcyvqsi) = zubevwxigo llnnotmlcb (jlnbtxfrxy, bianlopyda - ijftirjjex)
Phase 3
19
qmqkillqaf(denfekqlhr) = izpoetycjn tqrntwutmx (nsjyyespxx, gbxitwnwxe - gddqybrlux)
-
01 Oct 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free